Literature DB >> 6164924

gamma-Interferon induced by S. aureus protein A augments natural killing and ADCC.

W J Catalona, T L Ratliff, R E McCool.   

Abstract

Staphylococcus aureus produces a protein identified as protein A (SpA) with a molecular weight of 41,000 (ref. 1) which binds to the Fc region of many types of mammalian IgG2, activates complement, blocks opsonins and is both chemotactic and mitogenic. SpA has been used for various immunological purposes including removal of immune complexes, arming effector cells with antibody, distinguishing between antibody-dependent cell-mediated cytotoxicity (ADCC) and natural killing (NK), and exerting anti-tumor activity. We have now demonstrated that SpA induces the production of gamma interferon (IFN-gamma) in nonadherent, T lymphocyte-depleted (E-), Fc receptor-bearing (FcR+) human peripheral blood lymphocytes. Our data also suggest that IFN-gamma is a potent stimulator of both NK and ADCC activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164924     DOI: 10.1038/291077a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  21 in total

1.  Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy.

Authors:  Jonathan P Butchar; Payal Mehta; Steven E Justiniano; Kristan D Guenterberg; Sri-Vidya Kondadasula; Xiaokui Mo; Mahesh Chemudupati; Thirumala-Devi Kanneganti; Amal Amer; Natarajan Muthusamy; David Jarjoura; Clay B Marsh; William E Carson; John C Byrd; Susheela Tridandapani
Journal:  Clin Cancer Res       Date:  2010-03-23       Impact factor: 12.531

2.  Influence of alkali-treated cornsteep liquor containing medium on protein A production by Staphylococcus aureus.

Authors:  R G Muley; S Sarkar; S Ambedkar; S R Naik
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

3.  Antibody-dependent cell-mediated cytotoxicity. Effectors, signals, and mechanisms.

Authors:  E W Fuson; R A Hubbard; D G Sugantharaj; R B Andrews; M R Beard; R L Whittaker
Journal:  Surv Immunol Res       Date:  1983

4.  In vitro interferon producing activity of peripheral mononuclear cells in patients with chronic liver disease.

Authors:  K Matsushita; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-04

5.  Clinicopathologic responses in cats with feline leukemia virus-associated leukemia-lymphoma treated with staphylococcal protein A.

Authors:  R W Engelman; R D Tyler; L Q Trang; W T Liu; R A Good; N K Day
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

6.  The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells.

Authors:  Hong-Sheng Dai; Nathaniel Griffin; Chelsea Bolyard; Hsiaoyin Charlene Mao; Jianying Zhang; Timothy P Cripe; Tadahiro Suenaga; Hisashi Arase; Ichiro Nakano; E A Chiocca; Balveen Kaur; Jianhua Yu; Michael A Caligiuri
Journal:  Immunity       Date:  2017-07-18       Impact factor: 31.745

7.  In vivo protection by protein A of hepatic microsomal mixed function oxygenase system of cyclophosphamide-treated rats.

Authors:  M Dohadwala; P K Ray
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

8.  A Simple & Convenient Solid Phase Synthesis of Bacterial Origin Octapeptide Sequence, Glu-Asp-Gly-Asn-Lys-Pro-Gly-Lys-OH.

Authors:  Riaz A Khan
Journal:  Int J Pept Res Ther       Date:  2010-03-03       Impact factor: 1.931

9.  Antitumor activity with nontoxic doses of protein A.

Authors:  P K Ray; S Bandyopadhyay; M Dohadwala; P Canchanapan; J Mobini
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

10.  Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells.

Authors:  R Devos; H Cheroutre; Y Taya; W Degrave; H Van Heuverswyn; W Fiers
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.